namuscla
lupin europe gmbh - mexiletine hydrochloride - myotonic störningar - hjärtbehandling - namuscla är indicerat för symtomatisk behandling av myotonia hos vuxna patienter med icke-dystrofa myotonic störningar.
zenalpha
vetcare oy - medetomidine hydrochloride, vatinoxan hydrochloride - psykoleptika, hypnotika och lugnande medel - hundar - to provide restraint, sedation and analgesia during conduct of non-invasive, non-painful or mildly painful procedures and examinations intended to last no more than 30 minutes.
calmolan 0,26 mg depottablett
g.l. pharma gmbh - pramipexoldihydrokloridmonohydrat - depottablett - 0,26 mg - pramipexoldihydrokloridmonohydrat 0,375 mg aktiv substans - pramipexol
pramipexole hexal 0,26 mg depottablett
hexal a/s - pramipexoldihydrokloridmonohydrat - depottablett - 0,26 mg - pramipexoldihydrokloridmonohydrat 0,375 mg aktiv substans - pramipexol
calmolan 0,52 mg depottablett
g.l. pharma gmbh - pramipexoldihydrokloridmonohydrat - depottablett - 0,52 mg - pramipexoldihydrokloridmonohydrat 0,75 mg aktiv substans - pramipexol
pramipexole hexal 0,52 mg depottablett
hexal a/s - pramipexoldihydrokloridmonohydrat - depottablett - 0,52 mg - pramipexoldihydrokloridmonohydrat 0,75 mg aktiv substans - pramipexol
calmolan 1,05 mg depottablett
g.l. pharma gmbh - pramipexoldihydrokloridmonohydrat - depottablett - 1,05 mg - pramipexoldihydrokloridmonohydrat 1,5 mg aktiv substans - pramipexol
pramipexole hexal 1,05 mg depottablett
hexal a/s - pramipexoldihydrokloridmonohydrat - depottablett - 1,05 mg - pramipexoldihydrokloridmonohydrat 1,5 mg aktiv substans - pramipexol
calmolan 1,57 mg depottablett
g.l. pharma gmbh - pramipexoldihydrokloridmonohydrat - depottablett - 1,57 mg - pramipexoldihydrokloridmonohydrat 2,25 mg aktiv substans - pramipexol
pramipexole hexal 1,57 mg depottablett
hexal a/s - pramipexoldihydrokloridmonohydrat - depottablett - 1,57 mg - pramipexoldihydrokloridmonohydrat 2,25 mg aktiv substans - pramipexol